Definitive Healthcare Corp

Definitive Healthcare Corp(DH)股票分析

$1.125

-0.096 (-8.54%)收盘时

Loading chart…
最高
1.232
开盘
1.230
成交量加权均价
1.14
成交量
619.15K
市值
625.05M
最低
1.050
成交额
703.07K
企业价值/息税折旧摊销前利润(TTM)
3.35

Definitive Healthcare Corp. is engaged in transforming data, analytics, and expertise into healthcare commercial intelligence. The Company’s solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. It transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. Its business is conducted through AIDH TopCo, LLC (Definitive OpCo).

AI 分析 of Definitive Healthcare Corp (DH)

买入

Definitive Healthcare Corp (DH) is a good buy right now due to its current price of $1.13 being above the recent acquisition interest price of $1.02 per share, indicating potential upside. The stock has shown a positive trend with a 5-day change of +4.63% and a 20-day change of +14.58%, suggesting increasing investor interest. However, the main risk is the significant year-to-date decline of -52.42%, reflecting ongoing challenges in profitability.

估值指标

Definitive Healthcare Corp(DH)当前预期市盈率为 5.97,5 年平均预期市盈率为 38.08。

预期市盈率

合理
5 年均值 P/E
38.08
当前P/E
5.97
高估
74.79
低估
1.36

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
17.62
当前EV/EBITDA
3.35
高估
32.56
低估
2.69

预期市销率

合理
5 年均值 P/S
3.97
当前P/S
0.57
高估
7.50
低估
0.45

Alphio AI 对 DH 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%DH

$3.73

情景价格

基

基准

基准 · 50%DH

$3.39

情景价格

悲

悲观

悲观 · 25%DH

$3.31

情景价格

持有 DH 的大户

A

Advent International, L.P.

+ 持有DH

+3.43%

3个月收益率

事件时间线

2026-11-05 (ET)

17:30:00

Definitive Healthcare Reports Q3 Revenue of $54.65M

2026-11-04 (ET)

13:30:00

Definitive Healthcare Expands Leadership Team with New CPO and SVP of AI and Data

2026-09-02 (ET)

09:30:00

Definitive Healthcare Receives Acquisition Interest from Advent International

09:00:00

Definitive Healthcare Appoints Clay Ritchey as New CEO

2026-08-10 (ET)

17:00:00

Consensus 18c Narrows FY26 Revenue Outlook to $220M

资讯

DH 常见问题 —— 由 Alphio AI 解答

Definitive Healthcare Corp. is engaged in transforming data, analytics, and expertise into healthcare commercial intelligence. The Company’s solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. It transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. Its business is conducted through AIDH TopCo, LLC (Definitive OpCo). It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).

Definitive Healthcare Corp (DH) is a good buy right now due to its current price of $1.13 being above the recent acquisition interest price of $1.02 per share, indicating potential upside. The stock has shown a positive trend with a 5-day change of +4.63% and a 20-day change of +14.58%, suggesting increasing investor interest. However, the main risk is the significant year-to-date decline of -52.42%, reflecting ongoing challenges in profitability.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易